首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of clinical hypertension

缩写:J CLIN HYPERTENS

ISSN:1524-6175

e-ISSN:1751-7176

IF/分区:2.5/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引978
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Alan H Gradman Alan H Gradman
The goal of treating hypertension has evolved from merely lowering blood pressure to an emphasis on the more important objective of decreasing morbidity and mortality. Recent trials have emphasized, however, that the major benefit in outcom...
Rajani Dinavahi,Bonita Falkner Rajani Dinavahi
Elevated plasma homocysteine (Hcy) concentration is considered a risk factor for cardiovascular disease and may also be associated with hypertension. Although links have been established between hyperhomocysteinemia and elevated risk for ca...
Joseph L Izzo Jr,Marc S Weinberg,James W Hainer et al. Joseph L Izzo Jr et al.
The AMAZE (A Multicenter Trial Using Atacand and Zestril vs. Zestril to Evaluate the Effects on Lowering Blood Pressure) program included two identical studies sponsored by AstraZeneca LP. The oral form of candesartan is candesartan cilexet...
Karyn Bourke,Milan R Patel,L Michael Prisant et al. Karyn Bourke et al.
Untreated systemic hypertension is associated with retinopathy, optic neuropathy, and choroidopathy. Hypertensive choroidopathy is less common than retinal hemorrhages and infarcts seen with accelerated hypertension. The manifestations of c...
Marvin Moser,Vasilios Papademetriou,Thomas G Pickering et al. Marvin Moser et al.
In May 2004, a symposium updating the management of hypertension was held in Washington, DC. This was telecast to more than 200 medical facilities throughout the United States. Participants included Marvin Moser, MD, of the Yale University ...
Steven G Chrysant,George S Chrysant Steven G Chrysant
The angiotensin II receptor blockers (ARBs), are highly selective for the AT1 subtype and will block the effects of angiotensin II on peripheral vessels. Several short- and long-term studies have shown these agents to be safe and effective ...